Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study)

Selvin E(2016)Trends in insulin use and diabetes control in the U.S.: 1988–1994 and 1999–2012 Diabetes Care. 39 e33-e35

Parrinello CHM(2014)Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study Clin Endocrinol 80 47-56

Daya N(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412

Bergenstal RM(2017)Standards of medical care in diabetes—2017 Diabetes Care 40 S1-S135

Pablos-Velasco P(2016)Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin Diabetes Obes Metab 18 401-409

Parhofer KG(2007)Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study Br J Gen Pract 57 455-460

Bradley C(2007)Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy J Gen Intern Med 22 453-458

Stratton IM(2009)Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care. 32 193-203

Adler AI(2007)Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes J Diabetes Sci Technol. 1 540-548

Neil HA(2011)Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes Curr Med Res Opin 27 13-20

Selvin E(2016)Trends in insulin use and diabetes control in the U.S.: 1988–1994 and 1999–2012 Diabetes Care. 39 e33-e35

Parrinello CHM(2014)Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study Clin Endocrinol 80 47-56

Daya N(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412

Bergenstal RM(2017)Standards of medical care in diabetes—2017 Diabetes Care 40 S1-S135

Pablos-Velasco P(2016)Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin Diabetes Obes Metab 18 401-409

Parhofer KG(2007)Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study Br J Gen Pract 57 455-460

Bradley C(2007)Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy J Gen Intern Med 22 453-458

Stratton IM(2009)Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care. 32 193-203

Adler AI(2007)Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes J Diabetes Sci Technol. 1 540-548

Neil HA(2011)Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes Curr Med Res Opin 27 13-20